FRANKFURT--The following is a summary of analysts' forecasts for GlaxoSmithKline plc (GSK) first-quarter results, based on a poll of four analysts conducted by Dow Jones Newswires (figures in million pound, EPS, dividend and target price in pence, according to IFRS). Earnings figures are scheduled to be released May 6.

=== 
                           Core     Core        Core 
               Turnover  operat.  Pretax  Net attrib.  Core 
1st Quarter       total  profit   profit      profit    EPS 
AVERAGE           5,654   1,314    1,152         842   17.4 
Prev. Year        5,613   1,530    1,370       1,007   21.0 
+/- in %           +0.7     -14      -16         -16    -17 
 
MEDIAN            5,668   1,312    1,144         847   17.6 
Maximum           5,726   1,347    1,197         859   17.8 
Minimum           5,553   1,285    1,125         814   16.7 
Amount                4       4        4           4      4 
 
Bernstein         5,726   1,347    1,197         859   17.8 
Cowen and Company 5,620   1,285    1,125         835   17.4 
Deutsche Bank     5,553   1,292    1,136         814   16.7 
Jefferies         5,716   1,331    1,151         859   17.8 
 
 
            Target price    Rating                 DPS 2015 
AVERAGE            1,567    positive 1   AVERAGE       80.9 
Prev. Quarter      1,480    neutral  5   Prev. Year    80.0 
+/- in %            +5.8    negative 2   +/- in %      +1.1 
 
MEDIAN             1,550                 MEDIAN        80.0 
Maximum            1,700                 Maximum       84.0 
Minimum            1,440                 Minimum       80.0 
Amount                 7                 Amount           7 
 
Berenberg          1,615    Hold                       80.0 
Bernstein          1,541    Market perform             84.0 
Cowen and Company     --    Market perform               -- 
Credit Suisse      1,440    Underperform               80.0 
Deutsche Bank      1,600    Hold                       80.0 
Jefferies          1,520    Hold                       80.0 
Societe Generale   1,550    Sell                       82.4 
UBS                1,700    Buy                        80.0 
=== 

Year-earlier figures are as reported by the company.

DJG/err 

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

GSK (NYSE:GSK)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more GSK Charts.
GSK (NYSE:GSK)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more GSK Charts.